Company
OTCMKTS: BLGO
BioLargo Inc invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. The company accomplishes this by providing the capital, support, and expertise to expedite these disruptive technologies from "cradle" to "maturity". BioLargo monetizes through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. The company's patented technologies are all built to be best-in-class solutions to tough technical challenges, and they are backed up by world-class engineering and support services.
82 stories · page 2 of 5
The cleantech technologies provider said the customer contract is for the first phase of what is expected to be a multi-phase comprehensive per- and polyfluoroalkyl substances (PFAS) remediation project
The company generated approximately $1.3 million in revenue during the second quarter of 2022, a 37% increase from the first quarter of 2022, and a 185% increase from the second quarter of 2021
Ultra Safe Nuclear has invented a fourth-generation modular nuclear reactor, which can deliver safe, zero-carbon, cost-effective energy anywhere
“After investing years and millions of dollars into R&D for our innovative technologies, in this quarter we generated record revenues, our subsidiary ONM Environmental turned an operating profit, and our engineering subsidiary ended the qua
For the period ended March 31, 2022, the California-based group, which develops sustainable cleantech technologies and is a full-service environmental engineering company, reported revenue of $900,000
Consolidated revenue for the year ended December 31, 2021, was $2,531,000, which was a 4% increase over 2020
"We are making steady progress towards commercialization of our water treatment systems and have the benefit of working with experienced channel partners to get there,” said Calvert
BLEST’s Aqueous Electrostatic Concentrator was effective at functionally eliminating a toxic soup of PFAS from water provided by a large municipality in Southern California
The new wastewater treatment system is based on Garratt-Callahan's minimal liquid discharge (MLD) technology, which reduces the volume of wastewater discharge from industrial facilities, saving customers disposal fees while reducing strain
Under the agreement, ICS has been tasked to sell BioLargo’s two proprietary water treatment technologies
BioLargo CEO Dennis P. Calvert said Ikigai will purchase "the POOPH products from us, and in addition, we receive a royalty on sales"
For the three months ended September 30, 2021, the company generated $712,000, a 7% year-over-year increase
The company noted the article confirms that its Advanced Oxidation System (AOS) generates highly energetic iodine molecules likely responsible for the technology's elevated disinfection efficacy
In a wide-ranging letter to stockholders, CEO Dennis Calvert also noted that the company had the financing in place to meet its short-term needs
The program is described as offering peace of mind and proof of concept to customers who need PFAS water treatment solutions in the face of an uncertain and rapidly evolving technological and regulatory landscape
The company's fiscal overview noted an 11% increase in consolidated revenue which rose to $464,000, compared to the second quarter of 2020
The company's AEC technology has been proven to remove more than 99% of PFAS from contaminated water
The wins are expected to increase operating cash flow, which will support its plans for top-line revenue growth and efforts to commercialize several of its patented environmental technologies
The study shows the company's Advanced Oxidation System (AOS) generates less disinfection by-products than common wastewater treatment technologies
It recently paid off $406,000 in convertible debt that would have come due in August 2021 through cash and equity
